Evidence map›Paper›PMID 25394487›Full record

ArticleCell death and differentiation2015

Epo-induced erythroid maturation is dependent on Plcγ1 signaling.

T M Schnöder, P Arreba-Tutusaus, I Griehl, L Bullinger, M Buschbeck, S W Lane, K Döhner, C Plass, D B Lipka, F H Heidel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).Journal of cancer research and clinical oncology · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Oncogenic JAK2Science translational medicine · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.Journal of cancer research and clinical oncology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

T M SchnöderDepartment of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
P Arreba-TutusausDepartment of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
I GriehlDepartment of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
L BullingerInternal Medicine III, Department of Hematology/Oncology, University Hospital Ulm, Ulm, Germany.
M BuschbeckInstitute of Predictive and Personalized Medicine of Cancer (IMPPC), Campus Can Ruti, Badalona, Spain.
S W LaneDivision of Immunology, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Australia.
K DöhnerInternal Medicine III, Department of Hematology/Oncology, University Hospital Ulm, Ulm, Germany.
C PlassDivision of Epigenomics and Cancer Risk Factors (C010), German Cancer Research Center, Heidelberg, Germany.
D B Lipka1] Department of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany [2] Division of Epigenomics and Cancer Risk Factors (C010), German Cancer Research Center, Heidelberg, Germany.
F H HeidelDepartment of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
T FischerDepartment of Hematology and Oncology, Center for Internal Medicine, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
Otto-von-Guericke University Magdeburg · DEUniversity Hospital Ulm · DEGerman Cancer Research Center · DEHeidelberg University · DEInstitute of Predictive and Personalized Medicine of Cancer · ESQIMR Berghofer Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythropoiesis is a tightly regulated process. Development of red blood cells occurs through differentiation of hematopoietic stem cells (HSCs) into more committed progenitors and finally into erythrocytes. Binding of erythropoietin (Epo) to its receptor (EpoR) is required for erythropoiesis as it promotes survival and late maturation of erythroid progenitors. In vivo and in vitro studies have highlighted the requirement of EpoR signaling through Janus kinase 2 (Jak2) tyrosine kinase and Stat5a/b as a central pathway. Here, we demonstrate that phospholipase C gamma 1 (Plcγ1) is activated downstream of EpoR-Jak2 independently of Stat5. Plcγ1-deficient pro-erythroblasts and erythroid progenitors exhibited strong impairment in differentiation and colony-forming potential. In vivo, suppression of Plcγ1 in immunophenotypically defined HSCs (Lin(-)Sca1(+)KIT(+)CD48(-)CD150(+)) severely reduced erythroid development. To identify Plcγ1 effector molecules involved in regulation of erythroid differentiation, we assessed changes occurring at the global transcriptional and DNA methylation level after inactivation of Plcγ1. The top common downstream effector was H2afy2, which encodes for the histone variant macroH2A2 (mH2A2). Inactivation of mH2A2 expression recapitulated the effects of Plcγ1 depletion on erythroid maturation. Taken together, our findings identify Plcγ1 and its downstream target mH2A2, as a 'non-canonical' Epo signaling pathway essential for erythroid differentiation.

Indexed as

AnimalsApoptosisCell CycleCell DifferentiationCell ProliferationCells, CulturedDNA MethylationErythroblastsErythroid CellsErythropoiesisGene Expression ProfilingHigh-Throughput Nucleotide SequencingHistonesImmunoprecipitationJanus Kinase 2MiceHistonesJanus Kinase 2MACROH2A2 protein, humanPhospholipase C gammaReceptors, ErythropoietinSTAT5 Transcription Factor

Identifiers

PMID25394487
PMCPMC4423181
OpenAlexW2067523605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.